Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Roth Capital Downgrades Alexza Pharma (ALXA) to Neutral
August 8, 2014 6:44 AM EDTRoth Capital downgraded Alexza Pharma (NASDAQ: ALXA) from Buy to Neutral with a price target of $5.50 (from $10.00).
For an analyst ratings summary and ratings history on Alexza Pharma click here. For more ratings news on Alexza Pharma click here.
Shares of Alexza Pharma closed at $4.86 yesterday.
... More


